Cytori Therapeutics, Inc
Cytori Therapeutics, Inc:Cytori Therapeutics and Green Hospital Supply to Commercialize Celution™ System in Japan
Cytori Therapeutics, Inc. / Alliance
Release of an Ad hoc announcement according to § 15 WpHG, transmitted by
DGAP – a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
———————————————————————-
Cytori Therapeutics (NASDAQ: CYTX; Frankfurt: XMPA) and Green Hospital
Supply, Inc. (TYO: 3360), have partnered to commercialize Cytori’s
StemSource™ cell bank, which includes Cytori’s Celution™ System, to
hospitals throughout Japan. The partnership marks the first commercial
introduction of the Celution™ System and will target a market opportunity
estimated at more than $1 billion.
Under the agreement, Green Hospital Supply will be the exclusive Japanese
provider of both the StemSource™ banking platform and the Celution™ System
for stem and regenerative cell banking. Cytori retains exclusive rights for
both products in other countries. Revenues from all related product sales
will be shared equally between Cytori and Green Hospital Supply.
The StemSource™ cell bank, which features Cytori’s Celution™ System, is
designed to enable hospitals and clinics to become regenerative medicine
centers able to remove, process, retrieve and store regenerative cells from
a patient’s adipose tissue. Once installed, the cell bank may be offered as
an add-on banking procedure for hospital-admitted patients and in
conjunction with surgeries.
—————————————————————————
Information and Explaination of the Issuer to this News:
‘Our StemSource™ cell bank is a comprehensive automated platform that
incorporates the Celution™ System and related disposables to provide a
turnkey stem and regenerative cell banking operation for almost any
hospital or clinic in Japan,’ said Christopher J. Calhoun, CEO, Cytori
Therapeutics.
‘Stem cell banking is an underserved market in Japan, which is the second
largest medical market in the world,’ said Kunihisa Furukawa, President,
Green Hospital Supply. ‘Cytori’s products coupled with Green Hospital
Supply’s market leadership in the supply, outfitting and management of more
than 350 Japanese hospitals, makes this a compelling opportunity for both
companies. We intend to begin introduction of these products by the first
quarter of 2008, with a goal of installing cell banks in 250 hospitals by
2011.’
Cytori will webcast an investor conference call today at 10 a.m. Eastern
Daylight Time, in conjunction with the previously scheduled second quarter
financial results conference call, to discuss the transaction. The webcast
may be accessed at www.cytoritx.com.
DGAP 14.08.2007
———————————————————————-
Language: English
Issuer: Cytori Therapeutics, Inc.
6740 Top Gun Street
92121 San Diego, CA
Vereinigte Staaten von Amerika
Phone: 001-858 / 736 5485
Fax: 001-858 / 458 0994
E-mail: sbacher@cytoritx.com
Internet: www.cytoritx.com
ISIN: US23283K1051
WKN: A0ETV6
Indices: PRIMEALL, TECHALLSHARE
Listed: Geregelter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin, Stuttgart, München, Düsseldorf
End of News DGAP News-Service
—————————————————————————
Latest News
Latest Reports
Upcoming Events
No Events found